(ARRY) Array Biopharma complete technical analysis [charts+indicators] | Buy/Sell Array Biopharma | (ARRY) share price targets
Complete technical analysis of Array Biopharma (ARRY) by charts plus indicators, forecast predictions and share price targets for Array Biopharma (ARRY)
Array Biopharma trades in USA in Health Care sector.
10 day averaged volume of Array Biopharma is 5465832
| Date | Daily Closing Price | Open | High | Low | Volume |
| 15 Thu Jan 2026 | 9.88 | 9.38 | 9.97 | 9.37 | 0.463 times |
| 14 Wed Jan 2026 | 9.31 | 10.00 | 10.25 | 9.31 | 0.792 times |
| 13 Tue Jan 2026 | 10.00 | 10.10 | 10.30 | 9.69 | 1.306 times |
| 12 Mon Jan 2026 | 10.01 | 8.93 | 10.06 | 8.93 | 1.26 times |
| 09 Fri Jan 2026 | 8.99 | 9.00 | 9.41 | 8.83 | 0.512 times |
| 08 Thu Jan 2026 | 8.85 | 9.00 | 9.25 | 8.81 | 0.88 times |
| 07 Wed Jan 2026 | 9.05 | 9.45 | 9.45 | 8.81 | 1.055 times |
| 06 Tue Jan 2026 | 9.50 | 9.03 | 9.78 | 9.03 | 0.998 times |
| 05 Mon Jan 2026 | 9.03 | 9.81 | 9.82 | 8.94 | 1.044 times |
| 02 Fri Jan 2026 | 9.68 | 9.39 | 9.92 | 9.39 | 1.091 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 10 as stoploss in an intra day sell trade for a target of 9.51. However, stock will show a bullish move above 10.
Share price targets for Array Biopharma (ARRY)
| Target Type | Value |
| Downside Target | 6.54 |
| Downside Target | 7.13 |
| Downside Target | 7.34 |
| Downside Target | 8.18 |
| Downside Target | 8.81 |
| Downside Target | 9.19 |
| Downside Target | 9.43 |
| Downside Target | 9.82 |
| Upside Target | 10.21 |
| Upside Target | 10.30 |
| Upside Target | 10.47 |
| Upside Target | 10.90 |
Intraday share price targets for Array Biopharma (ARRY)
| Target Type | Value |
| Downside Intraday Target | 9.11 |
| Downside Intraday Target | 8.33 |
| Upside Intraday Target | 10.48 |
| Upside Intraday Target | 11.07 |
| Downside Intraday Target | 9.7 |
Weekly technical analysis of Array Biopharma (ARRY)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 15 Thu Jan 2026 | 9.88 | 8.93 | 10.30 | 8.93 | 0.852 times |
| 09 Fri Jan 2026 | 8.99 | 9.81 | 9.82 | 8.81 | 1.414 times |
| 02 Fri Jan 2026 | 9.68 | 10.10 | 10.21 | 9.19 | 1.092 times |
| 26 Fri Dec 2025 | 10.23 | 9.72 | 10.47 | 9.43 | 0.626 times |
| 19 Fri Dec 2025 | 9.49 | 8.61 | 9.58 | 8.30 | 0.785 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Array Biopharma (ARRY)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 15 Thu Jan 2026 | 9.88 | 9.39 | 10.30 | 8.81 | 0.468 times |
| 31 Wed Dec 2025 | 9.22 | 7.31 | 10.47 | 7.13 | 0.845 times |
| 28 Fri Nov 2025 | 7.51 | 8.02 | 9.58 | 6.54 | 0.955 times |
| 31 Fri Oct 2025 | 8.66 | 8.23 | 10.90 | 8.18 | 0.89 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Array Biopharma (ARRY)
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Array Biopharma ( (ARRY) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Array Biopharma stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Array Biopharma in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Array Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Array Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Array Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 9.47 and Array Biopharma (ARRY) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Array Biopharma (ARRY) stock. Volume based technical analysis of Array Biopharma (ARRY) stock is negative.
Array Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Array Biopharma ( (ARRY) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Array Biopharma stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Array Biopharma in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Array Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Array Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Array Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 9.47 and Array Biopharma (ARRY) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Array Biopharma (ARRY) stock. Volume based technical analysis of Array Biopharma (ARRY) stock is negative.
Array Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.